Kim S, Dodd RD, Mito JK, Ma Y, Kim Y, Riedel RF, Kirsch DG. Efficacy of phosphatidylinositol-3 kinase (PI3K) inhibitors in a primary mouse model of undifferentiated pleomorphic sarcoma (UPS). Sarcoma 2012

Lee DS, Kim SH, Kim S, Suh YJ, Kim HK, Shim BY. Prognostic significance of breast cancer subtype and p53 overexpression in patients with locally advanced or high-risk breast cancer treated using upfront modified radical mastectomy with or without post-mastectomy radiation therapy. Int J Clin Oncol 2012

Lee DS, Kim SH, Suh YJ, Kim S, Kim HK, Shim BY. Clinical implication of p53 overexpression in breast cancer patients younger than 50 years with a triple-negative subtype who undergo a modified radical mastectomy. Jpn J Clin Oncol 2011;41(7):854-66

Kim S, Kim K, Chie EK, Kim SW, Bang Y, Ha SW. Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy. Korean J HBP Surgery 2011;15(3):152-6

Kim S. In vitro radiosensitization of flavopiridol did not translated into in vivo radiosensitization. J Korean Soc Ther Radiol Oncol 2011;29(2):83-90

Lee JH, Kim SH, Kim SZ, Lee JH, Kim HK, Shim BY. Retrospective analysis of chemoradiotherapy for limited-stage small-cell lung cancer. J Korean Soc Ther Radiol Oncol 2009;27(3):133-9

Kim K, Kim S, Chie EK, Kim SW, Bang Y, Ha SW. Postoperative chemoradiotherapy of pancreatic cancer: What is the appropriate target volume of radiation therapy? Tumori 2005;91(6):493-7

Kim S, Kim SW, Bang YJ, Heo D, Ha SW. Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 2002;54(2):414-9

Kim S, Wu H, Heo D, Kim KH, Sung M, Park CI. Advanced hypopharyngeal carcinoma treatment results according to treatment modalities. Head & Neck 2001;23(9):713-7